BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28676709)

  • 1. Rectal cancer: No benefit for local excision over rectal excision.
    Dickson I
    Nat Rev Gastroenterol Hepatol; 2017 Aug; 14(8):450. PubMed ID: 28676709
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemoradiotherapy and Local Excision for Organ Preservation in Early Rectal Cancer-The End of the Beginning?
    Garcia-Aguilar J
    JAMA Surg; 2019 Jan; 154(1):54-55. PubMed ID: 30304376
    [No Abstract]   [Full Text] [Related]  

  • 3. [Outcome of watch and wait strategy or organ preservation for rectal cancer following neoadjuvant chemoradiotherapy: report of 35 cases from a single cancer center].
    Wu A; Wang L; Du C; Peng Y; Yao Y; Zhao J; Zhan T; Cai Y; Li Y; Sun Y; Ji J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Apr; 20(4):417-424. PubMed ID: 28440523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local excision after preoperative chemoradiation for T2 and T3 rectal cancers: is the wait over?
    Dossa F; Acuna SA; Baxter NN
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):422-424. PubMed ID: 32043981
    [No Abstract]   [Full Text] [Related]  

  • 5. Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer.
    Creavin B; Ryan E; Martin ST; Hanly A; O'Connell PR; Sheahan K; Winter DC
    Br J Cancer; 2017 Jan; 116(2):169-174. PubMed ID: 27997526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial.
    Rullier E; Rouanet P; Tuech JJ; Valverde A; Lelong B; Rivoire M; Faucheron JL; Jafari M; Portier G; Meunier B; Sileznieff I; Prudhomme M; Marchal F; Pocard M; Pezet D; Rullier A; Vendrely V; Denost Q; Asselineau J; Doussau A
    Lancet; 2017 Jul; 390(10093):469-479. PubMed ID: 28601342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
    Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
    Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Robotic transanal surgery for local excision of rectal neoplasia, transanal total mesorectal excision, and repair of complex fistulae: clinical experience with the first 18 cases at a single institution.
    Atallah S; Martin-Perez B; Parra-Davila E; deBeche-Adams T; Nassif G; Albert M; Larach S
    Tech Coloproctol; 2015 Jul; 19(7):401-10. PubMed ID: 25708682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic mesorectal excision with preservation of the pelvic autonomic nerves for rectal cancer.
    Fukunaga Y; Higashino M; Tanimura S; Kishida S; Fujiwara Y; Ogata A; Osugi H
    Hepatogastroenterology; 2007; 54(73):85-90. PubMed ID: 17419237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local excision for early stage rectal cancer in patients over age 65 years: 2000-2009.
    Gillern SM; Mahmoud NN; Paulson EC
    Dis Colon Rectum; 2015 Feb; 58(2):172-8. PubMed ID: 25585074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local excision for rectal carcinoma.
    Kim E; Hwang JM; Garcia-Aguilar J
    Clin Colorectal Cancer; 2008 Nov; 7(6):376-85. PubMed ID: 19036690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pros and cons of local excision procedures for early rectal cancer].
    Katsuno H; Maeda K; Koide Y
    Nihon Geka Gakkai Zasshi; 2011 Sep; 112(5):309-12. PubMed ID: 21941820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Will GRECCAR 2 be a game changer for the management of rectal cancer?
    Sun Myint A; Dhadda A; Rao C; Sripadam R; Gerard JP
    Colorectal Dis; 2020 Dec; 22(12):2330. PubMed ID: 32777139
    [No Abstract]   [Full Text] [Related]  

  • 14. Organ preservation in rectal cancer: have all questions been answered?
    Marijnen CA
    Lancet Oncol; 2015 Jan; 16(1):e13-22. PubMed ID: 25638548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rectal 'no man's land' and sphincter preservation during rectal excision.
    Williams NS
    Br J Surg; 2010 Dec; 97(12):1749-51. PubMed ID: 20949555
    [No Abstract]   [Full Text] [Related]  

  • 16. Advances in organ preserving strategies in rectal cancer patients.
    Stijns RCH; Tromp MR; Hugen N; de Wilt JHW
    Eur J Surg Oncol; 2018 Feb; 44(2):209-219. PubMed ID: 29275912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of transanal excision in the treatment of rectal cancer].
    Wang X; Liu Z; Miao D
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Jun; 17(6):544-6. PubMed ID: 24953358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of Babcock rectal cancer excision with preservation of the sphincter without preliminary colostomy].
    GOETZE O
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1950 Apr; 264():338-50. PubMed ID: 15426249
    [No Abstract]   [Full Text] [Related]  

  • 19. New Strategies in Rectal Cancer.
    São Julião GP; Habr-Gama A; Vailati BB; Araujo SEA; Fernandez LM; Perez RO
    Surg Clin North Am; 2017 Jun; 97(3):587-604. PubMed ID: 28501249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Features of Late Recurrence Following Transanal Local Excision for Early Rectal Cancer.
    Oh BY; Yun HR; Kim SH; Yun SH; Kim HC; Lee WY; Chun HK; Cho YB
    Dis Colon Rectum; 2015 Nov; 58(11):1041-7. PubMed ID: 26445176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.